Common blood test identifies benefits and risks of steroid treatment in COVID-19 patients

A new study confirms the findings of the large scale British trial of steroid use for COVID-19 patients and advances the research by answering several key questions: Which patients are most likely to benefit from steroid therapy? Could some of them be harmed? Can other formulations of steroids substitute for the agent studied in the British trial?

Leave a Reply

Your email address will not be published. Required fields are marked *